Join
Live feed
·
INSIDERFilingvia Quantisnow
Bolt Biotherapeutics Inc. logo

Chief Operating Officer Yonehiro Grant sold $43,807 worth of shares (13,176 units at $3.32), decreasing direct ownership by 43% to 17,269 units (SEC Form 4) to satisfy tax liability

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BOLT (Bolt Biotherapeutics Inc.) and more on Quantisnow.